2021-2025 North America Hemostasis Market Opportunities--USA, Canada, Mexico--Chromogenic, Immunodiagnostic, Molecular Coagulation Test Volume and Sales Segment Forecasts--Competitive Shares and Growth Strategies, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.
The report is available by section, and can be customized to specific information needs and budget.
The report explores business and technological trends; provides test volume and sales forecasts for 40 hemostasis procedures; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Rationale
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation diagnostics practice during the next five years.
New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
Coagulation Tests Analyzed in the Report
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrands Factor Fav/Ag, and others.
Country Analyses
Canada, Mexico, USA
Competitive Assessments
- Extensive strategic profiles of major suppliers and emerging market entrants.
Current and Emerging Products
- Review of established and emerging procedures.
- Comparison of automated and semi-automated analyzers marketed by Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.
Technology Review
- Analysis of current and emerging technologies and their potential market applications.
- Companies developing or marketing new technologies and products by test.
Strategic Recommendations
- Product development and business expansion opportunities with significant market appeal.
- Ideal product models with tentative prices and operating characteristics.
- Alternative market penetration strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks.
U.S. Molecular Diagnostics Market Assessment--2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
This report presents a comprehensive analysis of the US molecular diagnostics market, including: Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic,
USD 3850 View ReportU.K. Molecular Diagnostics Market Assessment--2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
This report presents analysis of the UK molecular diagnostics market, including:Major issues pertaining to the UK molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological
USD 3450 View ReportNorth America Nucleic Acid Testing Market Opportunities in the US, Canada, Mexico
North America Nucleic Acid Testing Market Opportunities in the US, Canada, MexicoThis new 3-country report is available by country, market segment, section, or individual test. The report is designed to
USD 9700 View ReportNorth America Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics Market—Growth Opportunities in the US, Canada, Mexico
North America Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics MarketGrowth Opportunities in the US, Canada, MexicoThe report is available by section, market segment, and can be customized to your
USD 6500 View ReportFill The Form For Sample Request